Thiotepa, Etoposide, Cyclophosphamide, ARA-C and Melphalan (TECAM) conditioning protocol for autologous stem cell transplantation - An alternative non BCNU containing regimen

被引：0
作者：
Grisariu, S. [1 ]
Shapira, M. Y. [1 ]
Or, R. [1 ]
Avni, B. [1 ]
机构：
[1] Hadassah Med Ctr, Bone Marrow Transplantat, IL-91120 Jerusalem, Israel
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P613
引用
收藏
页码：S441 / S441
页数：1
相关论文
共 50 条
  • [41] Comparison of the Low Toxicity Tecam Conditioning Regimen to BEAM in Patients with Lymphoma Requiring Autologous Stem Cell Transplantation
    Rosenberg, Dana
    Joffe, Erel
    Rozovski, Uri
    Perry, Chava
    Kirgner, Ilya
    Trestman, Svetlana
    Gur, Odelia
    Aviv, Freddy
    Sarid, Nadav
    Kolomansky, Albert
    Gepstein, Lily
    Herishanu, Yair
    Naparstek, Elizabeth
    BLOOD, 2015, 126 (23)
  • [42] Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen
    Farnault, L.
    Venton, G.
    Pourroy, B.
    Jourde-Chiche, N.
    Ivanov, V.
    Arcani, R.
    Roche, P.
    Mercier, C.
    Colle, J.
    Fanciullino, R.
    Costello, R. T.
    BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 1173 - 1175
  • [43] Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen
    L. Farnault
    G. Venton
    B. Pourroy
    N. Jourde-Chiche
    V. Ivanov
    R. Arcani
    P. Roche
    C. Mercier
    J. Colle
    R. Fanciullino
    RT Costello
    Bone Marrow Transplantation, 2019, 54 : 1173 - 1175
  • [44] Busilvex in combination with etoposide and melphalan as conditioning regimen in autologous haematopoietic cell transplantation for lymphomas: efficacy and safety
    Sakellari, I.
    Mallouri, D.
    Constantinou, V.
    Baliakas, P.
    Iskas, M.
    Karypidis, K.
    Apostolou, C.
    Kaloyannidis, P.
    Batsis, I.
    Vadikoliou, C.
    Papaemmanouil, S.
    Palladas, P.
    Smias, C.
    Anagnostopoulos, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S450 - S450
  • [45] Autologous Stem Cell Transplantation with Bendaeam (Bendamustine, Etoposide, Cytarabine, Melphalan) As Conditioning Regimen for Non-Hodgkin's Lymphoma and Hodgkin's Lymphoma
    Garciaz, Sylvain
    Coso, Diane
    Broussais, Florence
    Schiano, Jean-Marc
    Calmels, Boris
    Saillard, Colombe
    Boudin, Lauris
    Amrane, Sophie
    Blaise, Didier
    Bouabdallah, Reda
    BLOOD, 2014, 124 (21)
  • [46] LOMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN (LEAM) PROTOCOL AS CONDITIONING REGIMEN BEFORE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT) IN PATIENTS WITH LYMPHOMAS: A SINGLE CENTER EXPERIENCE
    Prka, Zeljko
    Vuk, Anamarija Vrkljan
    Cicic, David
    Soric, Ena
    Mitrovic, Zdravko
    Lucijanic, Marko
    Cikara, Marija Ivic
    Jonjic, Zeljko
    Pirsic, Mario
    Pejsa, Vlatko
    Jaksic, Ozren
    BONE MARROW TRANSPLANTATION, 2024, 59 : 267 - 268
  • [47] Long-term outcome after LACE (lomustine, ara-C, cyclophosphamide, etoposide) conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma
    Perz, JB
    Giles, C
    Szydlo, RM
    Wagner, S
    Sanz, J
    Chaidos, A
    Apperley, JF
    MacDonald, D
    Kanfer, E
    BONE MARROW TRANSPLANTATION, 2006, 37 : S240 - S240
  • [48] High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma
    Franca Falzetti
    Mauro Di Ianni
    Stelvio Ballanti
    Giuseppe Iodice
    Antonia Reale
    Olivia Minelli
    Gabriella Serio
    Massimo F. Martelli
    Franco Dammacco
    Angelo Vacca
    Roberto Ria
    Clinical and Experimental Medicine, 2012, 12 : 165 - 171
  • [49] High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma
    Falzetti, Franca
    Di Ianni, Mauro
    Ballanti, Stelvio
    Iodice, Giuseppe
    Reale, Antonia
    Minelli, Olivia
    Serio, Gabriella
    Martelli, Massimo F.
    Dammacco, Franco
    Vacca, Angelo
    Ria, Roberto
    CLINICAL AND EXPERIMENTAL MEDICINE, 2012, 12 (03) : 165 - 171
  • [50] Long-term follow up on patients with Hodgkin lymphoma treated with high-dose BCNU, etoposide, Ara-C, cyclophosphamide and autologous hemopoietic stem cell rescue.
    Gingrich, RD
    Hayashi, M
    Silverman, MM
    Lee, CK
    Hohl, RJ
    Schlueter, A
    BLOOD, 2001, 98 (11) : 392B - 392B
12345